Skip to content

Study on the mechanism of ovarian cancer progression of common gene mutation

Study on the mechanism of ovarian cancer progression of common gene mutation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043566
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

gene mutation group:No

Sponsors

Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Conform to ovarian cancer through imaging and pathological examination; 3. Give surgical treatment according to the actual condition of the patient; 4. Patient receiving intraoperative specimens for genetic testing; 5. No mental illness; 6. Consciousness, Relevant treatments can be completed according to doctor's orders; 7. not in special physiological periods such as pregnancy, breastfeeding, or puerperium; 8. patients and their families are fully aware of the contents of this study, etc.

Exclusion criteria

Exclusion criteria: 1. Patients with borderline ovarian cancer or unclear histology; 2. Patients with surgical contraindications, severe primary brain, heart, liver and kidney insufficiency, and coagulopathy; 3. Rejecting surgery Or direct radiotherapy and chemotherapy patients.

Design outcomes

Primary

MeasureTime frame
gene detection;

Countries

China

Contacts

Public ContactYa Xie

Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University

xieya838@126.com+86 13783550438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026